BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 17467549)

  • 41. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing.
    Farrell PM; Aronson RA; Hoffman G; Laessig RH
    Wis Med J; 1994 Aug; 93(8):415-21. PubMed ID: 7975706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newborn screening for cystic fibrosis: can one algorithm fit all?
    Caggana M
    Expert Rev Mol Diagn; 2017 Mar; 17(3):205-207. PubMed ID: 28127999
    [No Abstract]   [Full Text] [Related]  

  • 43. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease.
    Balascaková M; Holubová A; Skalická V; Zemková D; Kracmar P; Gonsorcíkova L; Camajová J; Piskácková T; Lebl J; Drevínek P; Gregor V; Vávrová V; Votava F; Macek M
    J Cyst Fibros; 2009 May; 8(3):224-7. PubMed ID: 19208501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newborn screening for cystic fibrosis: do we need a second IRT?
    Price JF
    Arch Dis Child; 2006 Mar; 91(3):209-10. PubMed ID: 16492882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen.
    Li L; Zhou Y; Bell CJ; Earley MC; Hannon WH; Mei JV
    J Med Screen; 2006; 13(2):79-84. PubMed ID: 16792830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening.
    Sermet-Gaudelus I; Mayell SJ; Southern KW;
    J Cyst Fibros; 2010 Sep; 9(5):323-9. PubMed ID: 20605539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population.
    Giusti R; Badgwell A; Iglesias AD;
    Pediatrics; 2007 Feb; 119(2):e460-7. PubMed ID: 17272608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PAP assays in newborn screening for cystic fibrosis: a population-based cost-effectiveness study.
    Seror V; Cao C; Roussey M; Giorgi R
    J Med Screen; 2016 Jun; 23(2):62-9. PubMed ID: 26304152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs.
    Martiniano SL; Croak K; Bonn G; Sontag MK; Sagel SD
    Mol Genet Metab; 2021; 134(1-2):65-67. PubMed ID: 34489170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European best practice guidelines for cystic fibrosis neonatal screening.
    Castellani C; Southern KW; Brownlee K; Dankert Roelse J; Duff A; Farrell M; Mehta A; Munck A; Pollitt R; Sermet-Gaudelus I; Wilcken B; Ballmann M; Corbetta C; de Monestrol I; Farrell P; Feilcke M; Férec C; Gartner S; Gaskin K; Hammermann J; Kashirskaya N; Loeber G; Macek M; Mehta G; Reiman A; Rizzotti P; Sammon A; Sands D; Smyth A; Sommerburg O; Torresani T; Travert G; Vernooij A; Elborn S
    J Cyst Fibros; 2009 May; 8(3):153-73. PubMed ID: 19246252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests.
    Ogino S; Flodman P; Wilson RB; Gold B; Grody WW
    Genet Med; 2005; 7(5):317-27. PubMed ID: 15915083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of population screening for carriers of cystic fibrosis.
    Smith MJ
    J Public Health Med; 1992 Sep; 14(3):257-63. PubMed ID: 1419203
    [No Abstract]   [Full Text] [Related]  

  • 53. Newborn screening for cystic fibrosis.
    Wallace J; Stein Q
    S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920
    [No Abstract]   [Full Text] [Related]  

  • 54. Overview of published evidence on outcomes with early diagnosis from large US observational studies.
    Rosenfeld M
    J Pediatr; 2005 Sep; 147(3 Suppl):S11-4. PubMed ID: 16202774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive Newborn Screening for Cystic Fibrosis, What to Do Next?
    Kumar P; Goyal JP
    Indian J Pediatr; 2019 Dec; 86(12):1147. PubMed ID: 31325101
    [No Abstract]   [Full Text] [Related]  

  • 56. [Neonatal screening for cystic fibrosis].
    Lucidi V; Lelli A; Castro M; Bella S; Ciuffetti C; Ravet P; Orrù M; Angeloni U; Angeloni P
    Pediatr Med Chir; 1994; 16(5):445-8. PubMed ID: 7885953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic Testing in Cystic Fibrosis.
    Brewington J; Clancy JP
    Clin Chest Med; 2016 Mar; 37(1):31-46. PubMed ID: 26857766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Newborn screening for cystic fibrosis.
    Castellani C; Massie J; Sontag M; Southern KW
    Lancet Respir Med; 2016 Aug; 4(8):653-661. PubMed ID: 27053341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Newborn screening for cystic fibrosis: techniques and strategies.
    Wilcken B
    J Inherit Metab Dis; 2007 Aug; 30(4):537-43. PubMed ID: 17505915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A false positive newborn screening result due to a complex allele carrying two frequent CF-causing variants.
    Bergougnoux A; Boureau-Wirth A; Rouzier C; Altieri JP; Verneau F; Larrieu L; Koenig M; Claustres M; Raynal C
    J Cyst Fibros; 2016 May; 15(3):309-12. PubMed ID: 27117206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.